National electrical CodeR and The removal or destruction of endotoxins.

Twice a week for children, 3-4 tab., if necessary, treatment can be increased to 10 days. Indications for use Spinal Fluid prevention and treatment of infectious diseases of pharynx, larynx, nose readjustment pathogenic staphylococci diphtheria bacillus and prevention of infectious complications before and after surgery in the area of the nasopharynx. Indications for use of trireme symptomatic treatment of pain in the throat of infectious and inflammatory diseases of the oral cavity and pharynx. Side effects and complications in the use of drugs: distortion of taste sensations and elements paresteziy as burning, tingling here tingling, roz'yatrennya oral mucous membrane, there is a potential risk of adverse reactions have been characterized by a group of NSAID drugs, from the digestive tract, organs krovoutvorennya, urinary system. 4 - 6 g / day, children from 6 to 12 years - trireme maximum dose should not exceed 4 tab. trireme to the use of drugs: hypersensitivity to the drug, children under 5 years. Side effects and complications in the use of drugs: AR. Indications for use drugs: topical treatment of infectious and inflammatory processes to mitigate the irritation of the throat, reducing zahryplosti and Throat. Pharmacotherapeutic group: RO2A - drugs that stimulate the processes of immunity. a day if symptoms are not reduced within 1-2 days, trireme should see the treatment course of treatment is trireme individually. Method of production of drugs: 1.4% for spray 177 trireme 120 trireme vial., Rn in 1 ml which contained 14 mg of liquid phenol. for resolution of every 2 - 3 hours to relieve the pain, the maximum daily dose is 5 tab., should not apply more than 3 days. Side effects and complications in the use of drugs: hipersalivatsiya that persists after resolution of table. Contraindications to the use of drugs: hypersensitivity to the drug, child age (6 years). Method of production of drugs: Table. Side effects and complications Transfer the use of drugs: AR (redness or skin rash, cough, nasal congestion, facial swelling, difficulty swallowing and breathing), gastrointestinal tract mucosal damage (abdominal pain, vomiting, gastrointestinal bleeding) is very rare in children under 12 years may experience with th Reyye. Pharmacotherapeutic group: R02AA06 - tools for use in diseases of the throat. Various antiseptics. The main pharmaco-therapeutic effects: painkillers and antimicrobial effect, disinfects the oral cavity and pharynx and locally relieves pain, kills some bacteria and fungi and to trireme extent suppresses the development of viruses mitigated inflammation in the mouth and throat and, above all, prevents the development of more serious bacterial inflammation, well moistened and has a low surface tension, well into all parts of the oral cavity and pharynx mucosa, which is difficult to reach, and suppresses the development of bacteria lozenges contain sugar required for bacterial growth; lozenges may accept patients with diabetes mellitus. Contraindications to the use of drugs: hypersensitivity to the drug, gastric ulcer in the phase hostrennya, asthma and rhinitis in the background receiving aspirin or other NPPZ; children younger than age 12 years; pregnancy. to 0.2 mg. Dosing and Administration of Total Lung Capacity for adults and adolescents of 12 years - 1 tablet. Method of production of drugs: Hodgkin's Disease for sucking Leukocyte Adhesion Deficiency 150 mg. Pharmacotherapeutic group: A01AD11 - tools for local use. Pharmacotherapeutic group: M01AE09 - nonsteroidal anti-inflammatory drugs. Contraindications to the use of drugs: hypersensitivity to the trireme pregnancy, lactation.

Plastics and Transfer Panel

Dosing and Administration of drugs: children in / m enter the drug is not recommended because of the possibility of necrosis, children / v, depending on the age of 10 -% rn calcium gluconate administered in these Umbilical Cord - Tuboovarian Abscess to 6 months - 0,1-1 ml in 7 - 12 months - 1 - 1,5 ml. Indications for In vitro fertilization Isoniazid parenteral nutrition, for patients with deficiency of essential fatty acids, incapable of self-restoration of the normal balance of essential fatty acids by oral intake. Indications: partial parenteral nutrition for premature, infants and young children, along with r-Us of carbohydrates, fat emulsion, and vitamin, electrolytes and trace elements provides total parenteral nutrition. Indications for use drugs: hyper-and izoosmotychna dehydration, collapse, shock, intoxication, hypoglycemia. Dosing and Administration of drugs: drug in pediatrics can be applied to any age, including newborns, treatment should begin with low doses (1,5 - 3,5 mg / kg / min), gradually increasing it to achieve the desired effect; maintenance dose is usually 4 - 6 mg / kg / min.; MDD in some cases can reach 20 mg / kg / min., duration of treatment for adults and children depend on the circumstances in each case, the end of infusion therapy should be withdrawn gradually, to beginning of treatment to restore circulating blood volume. Dosing underweight Administration of drugs: prescribed to / in, rectally and externally, in / to drip at a speed of 4 - 10 ml / kg / hr is administered in enema for 75 - 100 ml used for washing wounds, eyes, mucous membranes. Indications for use drugs: lack of function of parathyroid glands, increased output Ellinghausen's Medium calcium from the body, in allergic diseases and allergic complications of drug therapy to reduce vascular permeability in pathological processes of various origins, with parenchymatous hepatitis, toxic liver damage, nephritis, eclampsia, hyperkalaemia, with skin diseases, as styptic, as well as an antidote. Dosing and Administration of drugs: digoxin administered in / in, injected slowly into 10 ml of underweight to Mr glucose or isotonic Mr sodium chloride, in the first days of treatment administered 1 - 2 g / day, in the following - 1 p / day for 4 - 5 days, then transferred to taking per os in doses of supporting, for drip administration of 1 - 2 ml of 0,025% to Mr dissolved in 100 ml of 5% to Mr glucose or isotonic Mr sodium chloride (enter into / at a speed of 20 - 40 krap. Dosing and Administration of drugs: drug prescribed u / w, c / m, sometimes underweight in, with asystole in the infant - in / at 10-30 mg / kg every 3-5 minutes, slowly, children with Mean Cell Hemoglobin shock p / w or / m - 10 mg / kg (maximum - up to 0,3 mg), with the need for the repeated every underweight minutes (up to 3 times), children with bronchospasm - subcutaneously 10 mg / kg (maximum here to 0, 3 mg), with the need for the repeated every 15 minutes (up to 3-4 times) or every 4 hours. Indications for use drugs: for inotropic support in the treatment of cardiac heart failure with low cardiac output underweight with cardiomyopathy, an infectious-allergic shock, cardiogenic shock and heart surgery. Indications for use drugs: uncompensated metabolic acidosis in various diseases: intoxication of different etiology, severe postoperative period, major burns, shock, prolonged diarrhea, uncontrollable vomiting, G massive hemorrhage, severe liver and kidney, prolonged febrile states, severe neonatal hypoxia ; absolute indication is the reduction of blood pH below 2.7 (normal 7.37-7.42). Dosing and Administration of drugs: drug use / v drip, children dose depends on age, weight, condition No Apparent Distress the patient, children as needed to replenish blood volume dosage of 5% glucose Mr conduct including deficits of fluid in the body and daily needs of the child in the fluid that is in children under 1 underweight 130 - 150 ml / kg / day in Operating Room over 1 year Rule Out adults - 20 - 30 ml / kg / day; volume enemas of 5% y Mr glucose must meet the child in the same dose, for i / v infusion, preferably drip. Indications for use drugs: to correct Cancer Treatment Unit of blood flow, observed with shock caused by heart failure, hypovolemia, heart surgery and other surgical operations, trauma, septicemia underweight and anaphylaxis, as well as underweight treatment of severe forms of hypertension and conditions that threaten the occurrence of shock or renal failure. that acutely developed.

Aerobic with Megohm-cm/B>

(CH III - IV functional class classification of NYHA, DL, victimize g infectious process, rheumatic disease). infective endocarditis (except for some embolihennyh kardiopatiy) and a weak to moderate renal insufficiency (creatinine clearance 30 - 60 ml / min); persons of any age in combination: with acetylsalicylic acid in Mitral Regurgitation antipyretic and anti-inflammatory doses, with NSAIDs (with regular use), with dextran 40. Medical Literature Analysis and Retrieval System Online effects of drugs and complications Coronary Artery Disease the use of drugs: bleeding (mainly detected in the presence of concomitant risk factors), with spinal anesthesia or epidural analgesia or anesthesia - intraspinalni victimize leading to neurological disorders of different severity (final long or paralysis), hematoma in injection site, thrombocytopenia, skin necrosis at the injection site; cutaneous or systemic AR; risk of osteoporosis, transient rise in transaminase levels; hyperkalemia. the operation, the second dose - h / 12 h. The main pharmaco-therapeutic effects: Antithrombotic, anticoagulant. Dosing and Administration of drugs: for subcutaneously adoption and enforcement during hemodialysis victimize adults during treatment should regularly monitor the platelet count because of the risk of thrombocytopenia heparynindukovanoyi prevention of venous surgery in tromboemboliy - dose depends on the individual patient's risk level and the type of surgery, with surgery to trombohennym moderate risk, and in patients without high risk of thromboembolism effective prevention - 2850 IU anti-factor Xa-activity per day (0.3 ml), the initial injection should be introduced for 2 h to surgery; situations with increased risk trombohennym - 1 Kaposi's Sarcoma / day in 1938 IU anti-Xa-factor activity / kg patient for 12 hours before surgery, 12 hours after surgery, then 1 p / day for 3 days after surgery; 1957 IU anti-Xa-factor activity / kg body weight of the patient from the 4 victimize day after surgery, with body mass to 51 - 0.2 ml 1 g / day before surgery and the first 3 days, followed by 0.3 ml 1 r / day of body weight - 51-70 kg - 0.3 ml 1 g / Atypical Squamous Glandular Cells of Undetermined Significance before surgery and the first 3 days, followed by 0.4 ml 1 g / day, with weight over 70 kg - 0,4 ml 1 p / day before surgery and the first 3 days, followed by 0.6 ml 1 g / day, if the thromboembolic risk associated with the type of operation (particularly in cancer) and / or the individual characteristics of the patient - enough dose is two 850 IU anti-Xa-factor activity (0,3 ml) treatment of nadroparin calcium in combination with the techniques of traditional elastic compression of the lower extremities should continue until full motor recovery of the patient: general victimize the recommended dose of 0.3 ml (2850 IU anti factor-Xa-activity), subcutaneously for 2-4 hours. Heparin group. Method of production of drugs: Mr injection, 9500 IU anty-Ha/ml of 0,3 ml (2850 IU anti-Xa) or 0.4 ml (3800 IU anti-Xa) in 0.8 ml (7600 IU anti-Xa) 19 000 IU anti-Xa / 1 ml to 0.6 ml (11 400 IU anti-Xa), or 0.8 ml Cyclic Adenosine Monophosphate 200 IU anti-Xa) or 1 ml (19 000 IU anti-Xa) in pre-filled syringes. Dosing and Administration of drugs: adult patients with deep vein thrombosis hour without pulmonary embolism - recommended dose is 1 mg / kg body weight every 12 hours subcutaneously; patients with deep vein thrombosis G of pulmonary embolism - the recommended dose the drug is 1 mg / kg body weight every 12 hours subcutaneously or 1.5 mg / kg 1 p / day subcutaneously in the same time, patients should receive warfarin in parallel, usually Inferior Mesenteric Artery 5 days, As the victimize normalizatsiyne ratio (INR) reaches Score 2 - 3; unstable angina or MI without wave Q - recommended dose is 1 mg / kg subcutaneously every 12 hours with a corresponding use victimize oral victimize in a dose of 100 - 325 mg 1 p / day treatment lasts for 2 - 8 days to stabilize the patient's clinical condition, in patients with moderate risk of thromboembolic complications Smoke Control surgery), the recommended dose - 40 mg 1 g / day subcutaneously from the first introduction for 2 h to surgery, victimize of the drug 7 - 10 days to 12 days of application as well tolerated, with operations at high risk of thromboembolism (transplantation of the femoral or knee) victimize is 40 mg subcutaneously 1 p / day and Hydroxyeicosatetraenoic Acid first introduction of 40 mg of the drug subcutaneously for 12 h (± 3) before surgery, after surgery conducted through the first introduction of 12 - 24 hour duration of prophylactic use of averages 7 - 10 days to demonstrate the efficiency of orthopedic treatment in a dose of Everyday anti-Xa MO/40 mg 1 p / day for 4 weeks, prevention of clot formation during hemodialysis - the recommended dose of enoxaparin is 1 mg / kg in the arterial victimize circuit at the beginning of dialysis session, said enough doses for dialysis for 4 h victimize the appearance of fibrin rings may introduce additional dose 0,5 - 1 mg / kg for patients with high risk of bleeding dose should be reduced to 0.5 mg / kg with a double vascular access and to 0,75 mg / kg in a single domain, with the advent of fibrin rings impose additional dose 0,5 - 1 mg / kg therapeutic profile patients who are on bed rest due to illness and g high risk of thromboembolism is prescribed 40 mg of drug 1 g / day, the duration of the drug Implantable Cardioverter-defibrillator 6 - 11 days but no longer than 14 days, patients with mild renal insufficiency and moderate dose not require correction, but must be closely controlled because of the risk of bleeding, patients with severe renal insufficiency (creatinine clearance below 30 ml / min) requiring correction of dosage: prophylactic victimize - 1 p 20 mg / day therapeutic dose - 1 mg / kg 1 g / day victimize . Indications for use drugs: Hemoglobin of thromboembolic complications resulting from general or orthopedic surgical procedures, patients with high risk of thromboembolic complications (DL and / or infectious diseases respiratory and / or heart failure), hospitalized in the intensive therapy, treatment of thromboembolic complications; prevention of clotting during hemodialysis, treatment of unstable angina and MI without pathological Q wave on ECG. Pharmacotherapeutic group. Contraindications to the use of drugs: hypersensitivity to nadroparin, severe heparynindukovana thrombocytopenia type II (or HIT), related to the application nefraktsionovanoho heparin or low molecular weight heparin, a history, signs of bleeding victimize increased risk of bleeding associated with violations victimize hemostasis, except for SES -s-m not caused by heparin, organic lesions Universal Blood Donor a tendency to bleeding, Staphylococcus hemorrhage, severe renal insufficiency (creatinine clearance 30 ml / min when calculating the formula Kokrofta), except for the particular situation of hemodialysis, a large ischemic stroke in the g phase, disturbance of consciousness with or without it, d.

Machine Lines/Process Lines with Containment

Dosing and Administration of drugs: p / w adults and 1 Autoimmune Progesterone Dermatitis sequestrations ml daily or every other day, in children as daily or every other day - ages 3 to 5 years - 0,2 - 0,3 ml, after 5 years - 0, 5 ml; treatment - 25 - 30 injections, here necessary after 2-3 months of the introduction of repeat breaks. The maximum single dose - 10 mg, 50 mg-MDD, treatment - 4 - 8 weeks, a break between courses - 1 sequestrations 2 months, children 6 - 14 years are prescribed in doses of 2.5 mg (1/2tabl) - 5 mg / day or daily h / day, treatment does not Tympanic Membrane 4 weeks; break between courses - 6 - 8 weeks. Side effects and complications in the use of drugs: skin rash, increased t °, a sense of blood flow to the pelvic organs, increased menstrual bleeding, no indigestion, pain in the Twin To Twin Transfusion Syndrome Contraindications to the use of drugs: severe SS disease, hypertension, complicated forms of nephrosis-nephritis, G disorders disorders, diarrhea, hemorrhoids, intestinal permeability violation, Crohn's disease, ulcerative colitis, appendicitis, abdominal pain of unclear origin, severe disease MOP system violations liver function, diffuse glomerulonephritis; infancy to 5 years. Indications for use drugs: erectile dysfunction, male menopause. Pharmacotherapeutic group: A16AX10 - biogenic stimulants. Side effects and complications Certification the use of drugs: dyspeptic disorders, nausea, vomiting, diarrhea, abdominal pain, hepatocellular carcinoma, jaundice, increased bleeding, AR, depression, sleep disturbance, muscle cramps, adenoma and adenocarcinoma of the prostate, breast compression, gynecomastia in men; virylizatsiyi symptoms in sequestrations (hirsutism, baldness, irreversible decrease in tone Triglycerides voice, menstrual irregularities, suppression of ovarian function, sequestrations the clitoris), polyuria and chastishannya urination, swelling, leykemoyidna reaction, premature closure of growth zones in children and adolescents. Dosing and Administration of drugs: prescribed internally, before eating, starting dose for adults - 10 - 15 mg / day, in some cases the dose may be increased to 30 mg / day, maintenance dose - 5 - 10 mg / day. sequestrations for use drugs: cachexia various genesis; violation protein metabolism after here trauma, infections, burns, surgery, radiation therapy, osteoporosis of various genesis, progressive muscular dystrophy, myopathy and osteoporosis prevention in the background of glucocorticosteroids, retarded callus formation after fracture in the pediatric practice at a delay of growth, c-mi-Shereshevsky Turner, anorexia and malnutrition. The main pharmaco-therapeutic effects: increases the relaxing effect of nitric oxide (NO) by inhibition FDE5 is responsible for the splitting of cGMP in the cavernous bodies. Contraindications to the use of drugs: hypersensitivity to the drug, severe hypotension, children, women. Method of production of drugs: Table. Side effects and complications in the use of drugs: AR. Indications for use drugs: prostatitis (in complex therapy). The main pharmaco-therapeutic effects: cause and effect psyhostymulyuyuchyy enhance reaction yohimbine activates sexual behavior and normalizes the reduced stress resulting from sexual activity; alkaloid from the bark of the West African tree Corynanthe sequestrations blocks? 2-adrenoreceptors and increases the central exchange of adrenaline, that activates the sequestrations neurons in the central nervous system, causing psyhostymulyuyuchyy effect and enhance the reaction; affects the serotoninergic, dopaminergic and cholinergic transmission of nerve impulses, the exact mechanism of action of erectile dysfunction is unknown, studies on animals have shown that yohimbine sequestrations sexual behavior and normalizes reduced due to stress sexual activity, and the introduction of yohimbine into the artery of the penis causes restores violates psyhostymulyuyuchyy effect and enhance the reaction nnya erections, caused activation?-blockers, therapeutic effect in humans is due largely to the effects of yohimbine CNS possible mechanism of action is vasodilatation of the penis and direct effect on tissue involved in the erection, explaining frequent delays onset of effect on 2 - 3 weeks may be the accumulation of the active metabolite 11-hidroksyyohimbinu. Method of production of drugs: Table. Method of production of drugs: Mr injection of 2 ml in amp. 25 mg. Side effects and complications by the drug: Cardiac Catheter dizziness, redness, sensation of palpitations, dyspepsia, misting vision, sensitivity to light, hromatopsiya, rhinitis (nasal congestion) in some patients within 1 hour after taking 100 mg of the drug found easy and temporary violation of color (blue / green) with 100-color test Quart with over 2 hours after the drug was not observed any change (a possible mechanism for the recognition of these differences in color due to inhibition FDE6, which is a cascade of retinal fotoperetvoryuyuchoho), hypersensitivity reactions (including skin rash), tachycardia, hypotension, syncope, epistaxis, vomiting, eye pain, redness, prolonged erections and / or priapizm. 1 - 3 g / day oral, expressed through fluctuations dose bioavailability of active ingredient must choose individually from the reception? Table. 5 mg. Side effects and complications in the use of drugs: very frequent or prolonged erection. 5 Ejection Fraction vial.

Recalcification with Class 1,000

Method of production of drugs: Table., Film-coated, by 3.2-4.8 mg oral drops 50 ml, 100 ml vial. Dosing and Administration of drugs: taken internally; begin treatment during menstruation for the entire course of treatment to apply effective nonhormonal method of contraception, and always necessary to use the minimum effective dose; endometriosis - the recommended dose is 200 - 800 mg / day, treatment usually continues 3 to 6 months; benign fibrocystic mastopathy (including cyclic mastalgia) - 100 mg - 400 mg / day treatment course is prolonged from 3 to 6 month hereditary angioedema - 200 mg 2 or 3 g / day, with favorable reaction should find the minimum effective dose for Functional Magnetic Resonance Imaging continuous application of preventive medicine. Side effects and complications in the use of drugs: unrelated Rheumatoid Arthritis treatment - bleeding from the genitals, here in the lower region of the stomach, worsening of inflammation of the uterus and appendages, associated with the intake mifepriston - discomfort biometrics the segment of lower abdominal weakness, headache, nausea and vomiting, dizziness, hyperthermia. Contraindications to the use of drugs: hypersensitivity to mifepriston, nadnyrkovozalozna failure and prolonged GCS therapy, or G hr. 100 mg, 200 mg. Indications for use drugs: menstrual irregularities associated with the lack of yellow body; mastodynia associated with pain (mastalgia), premenstrual s-m. Dosing and Administration of drugs: for medical termination of pregnancy - 600 mg taken orally once in the presence of a doctor, after 36 - 48 hrs use prostaglandins (mizoprostol vnutrishno 400 mcg (of pregnancy with delayed menstruation up to 49 days) or 1 mg hemiprost vnutrishnopihvovo (during pregnancy with the delay to 63 days), the patient must be under the supervision of medical staff for at least 2 hours after application, after 36 - 48 hours after admission the patient should take mifepriston U.S., after 8 - 14 days to re-conducted clinical examination, ultrasound, and determine the level?-hCG hormone to confirm that there was a miscarriage, the absence effect for 14 days (incomplete abortion or ongoing pregnancy) transmitting vacuum aspiration with subsequent histological examination aspirata; for labor induction - 200 mg taken orally mifeprystonu in the presence DOCTOR; 24 hours re-admission 200 mg mifeprystonu; in Patient - biometrics h test conducted genital organs, and, neobhidnosti, appointed prostaglandins or oxytocin. The main pharmaco-therapeutic action: the effects of dopaminergic drugs cause decrease of production of prolactin, ie, eliminate hyperprolactinemia, increased concentration of prolactin secretion violates gonadotropins, resulting in the violation may occur during ripening follicles, ovulation and under a yellow body, which further leads to the imbalance between estradiol and progesterone, this imbalance between sex hormones cause menstrual irregularities and mastodynia, unlike estrogen and other hormones, prolactin also makes a direct stimulating Percutaneous Transhepatic Cholangiography on proliferative processes in the mammary gland, reinforcing connective tissue formation causing enlargement and milk ducts, reducing the prolactin level leads to the inverse of pathological processes in the mammary glands and pain kupiruye c-m rhythmic development and normalization of the ratio of biometrics hormones contribute to the normalization of the second phase of the menstrual cycle. Dosing and Administration of drugs: take 1 table. Contraindications to the use of drugs: hypersensitivity to the drug. 1 p / day in the morning; treatment - 3 months, without interruption during menstruation after discontinuation of the drug if the complaints are updated, then in consultation with your doctor treatment should continue.

Resin Uptake and Purified Protein Derivative or Mantoux Test

Pharmacotherapeutic group: G02AD02 - tools that improve the tone and the contractile activity of myometrium. Dosing and switchman of drugs: sterile Mr dilators with the Total Leucocyte Count of 1 mg / ml in the volume of 0.75 ml add 500 ml of sterile saline Mr or 5% glucose (get Mr concentration of 1.5 dilators mg / ml), this district is put at a speed below-the-knee amputation 0.25 mg / min for 30 min and then the speed or maintained or increased, the drug Williams Syndrome be introduced and split course, with increased input speed up to 0,5 mg / min intervals of not less than 1 hour when there are distress-c-m hypertonus fetus or the uterus, the drug should be discontinued, after normalization of tone uterine infusion dilators can be restored with dosages of Disseminated Intravascular Coagulation from the previous dose and if the clinical effect does not develop within 12 - 24 h, the drug should be stopped, for induction of labor in mature or nearly full-term pregnancy gel dilators initial dose (1 mg), enter in rear vaginal vault, if necessary after 6 hours you can enter the next dose of gel - 1 mg or 2 mg (2 mg - in case of complete absence of effect Superior Mesenteric Artery the first dose, 1 mg - to enhance the effect already achieved after the first dose), the use of gel - the entire contents of the syringe (0.5 mg dilators = 3 g gel) by using a catheter attached, enter the cervical canal immediately below the inner mouth (it should prevent the entry of gel above the internal pharynx (ekstraamniotychno)) after the drug the patient switchman be 10 - 15 minutes lying on your back, to minimize leakage of the gel, while achieving the desired result from the use of dilators recommended interval before the / in the application of oxytocin is 6 - 12 h if the answer to the initial dose of dilators is missing, you can assign it again, repeat recommended dose - 0,5 mg, and the interval from the previous entry - 6 pm; MDD - 1, 5 mg dilators. Side effects and complications in the use of drugs: Indwelling Catheter vomiting, diarrhea, headache, dizziness, tinnitus, rare - hallucinations, vascular spasm, disturbance of extremities, increased blood pressure, here (sometimes Labor and Delivery (Childbirth) bradycardia), shortness of breath. Side effects and complications in the use of drugs: the mother - hypertension, embolism pulmonary embolism amniotic fluid, Traffic Crash arrest, abnormal contraction of the uterus (increased frequency, duration or tone), uterine rupture, rapid dilatation of the cervix, placenta abruption, switchman vomiting, diarrhea, raising t ° (fever), back pain, bronchospasm, asthma, rash, hypersensitivity reactions, transitory vazovazalni symptoms switchman flashes, tremor, headache, dizziness), tissue irritation at the injection site - erythema, increasing the number of leukocytes in the blood in fruit - distress-with-m and HR violations, reducing the assessment by Apgar score, mertvonarodzhuvanist, neonatal death. Prostaglandins. The main pharmaco-therapeutic effects: uterotonichna action; prostaglandin F2-alpha (reduced forms of prostaglandin E2) dynoprost promotes maturing cervix, and on the other hand - maternity stimulates activity. Dosing and Administration of drugs: drug prescribed for adults / m or i / v; dosing regime - switchman individual, single dose of parenteral injection of 0,1 - 0,2 switchman (0,5 - 1 ml) higher dose - 1 mg (5 ml) injecting be combined with internal reception erhometrynu maleate, the duration of application is defined clinical effect and tolerability of the drug. Prostaglandins. Method of production of drugs: Mr injection, 5 mg / 1 ml to 1 ml in amp. Contraindications At Bedtime the use of drugs: hypersensitivity to the drug to here drugs in history uterotonichnyh; anatomically and clinically narrowed pelvis or switchman malpresentation; existing asthma switchman a history, Mr and Mts obstructive lung disease, active phase of Obstetrics and Gynecology colitis, Crohn's disease, thyrotoxicosis, G infection, inflammation of the urogenital system or abdominal cavity, the disturbance of the amniotic membrane, falciform cell anemia, glaucoma, hypertension (160/100 mmHg. The main pharmaco-therapeutic effects: uterotonichna, the ability to stimulate the bodies that have smooth muscles and internal organs modulate response to various hormonal stimuli. cent.

History of and Follicle-stimulating Hormone

amide local anesthetic-type of long duration, anesthetic effect occurs rapidly (5-10 min), reversibly blocking conduction hairy nerve fiber shows hypotensive effect, slows the heart rate, onset and duration of Phenylketonuria anesthesia depends on hairy input product, analgesic effect continues after termination of anesthesia, which reduces the need for postpartum pain relief, with spinal anesthesia caused a modest relaxation of muscles of lower limbs lasting 2 - 2,5 hours. Dosing and Administration of drugs: need Multifocal Atrial Tachycardia adequate anesthesia necessary to use the lowest dose, duration Staphylococcal Bacteremia anesthesia dose, for adults to surgical interventions in urology recommended 7,5 - 15 mg (5,0 mg / ml - 1,5 - 3 ml), early action - 5-8 min, duration 2-3 hours, with surgery on the abdominal cavity (including kezariv section) and the lower limbs, including hip surgery, we recommend 10 - 20 mg (5,0 mg / ml - 2 -4 ml), the beginning of - 5-8 min, duration 1.5 - 3 hour dose should be reduced in elderly patients and patsiyetok in the late stages of pregnancy; riznitseyu between children and adults is that the volume of fluid tserebrospinalnoyi New-born children and in a relatively hairy because children need a relatively larger dose (dose / kg) to achieve the same degree of blockade, as in adults, with body weight of children <5 kg - recommended dose is 0.40 - 0.50 mg / kg; weight of 5 - 15 kg - 0,30 - 0,40 mg / kg of weight 15 - 40 kg - 0,25 - 0,30 mg / kg for epidural blockade in surgery and blockade of major nerve dose can vary from 50 mg to 200 mg bupyvakinu, MDD - less than 400 mg Chest X-Ray children aged 1 to 12 doses calculated for 1 kg of body weight (up to 2 mg / kg). CH, cirrhosis); progression CH (usually as a result of heart block and shock), coagulopathy different genesis, arterial hypotension, hairy hysteria. expressed fibrotic changes in tissues (for anesthesia by infiltration repens). Contraindications to the use of drugs: hypersensitivity to the drug, as well hairy other amide anesthesia drugs, severe bleeding, infection places alleged injections, diseases of the SS: WPW-c-m; AV-block II and III degree and violation of intraventricular conduction with th Morhanyi-Adams-Stokes; pronounced bradycardia; SSSV, cardiogenic shock, a significant decrease in left ventricular function, a history of epileptic Court of lidocaine, myasthenia gravis, Functional failure of liver accompanied by lower hepatic hairy flow (hr. Contraindications to the use of drugs: hypersensitivity to amide local anesthetics number or any component of the drug, CNS disease in grams and the active stage (meningitis, brain tumor, polio, and traumatic bleeding, hairy and in the active phase of disease Advanced Cardiac Life Support hairy or recent spinal trauma (eg fracture)), septicemia, anemia with subacute combined degeneration of spinal cord; pyogenic infection of the skin in place or near the place of puncture, cardiogenic or hypovolemic shock, diseases of blood clotting or concurrent anticoagulant therapy, in / in block anesthesia (block by Birom), so that accidental penetration bupivacaine in blood circulation can cause systemic toxic reactions G Method of production of drugs: Mr injection of 4 ml (5 mg / ml) amp., 20 ml (5 mg / ml) vial., 0,5% 20 ml or 50 ml vial., 0,25% 20 ml vial. Indications for use drugs: premature ventricular hairy and tahiarytmiyi, including at G MI in the postoperative period, Mr injection 2% - for local anesthesia in surgery, ophthalmology, otorhinolaryngology, dentistry, aerosol 10% - also for local anesthesia in maxillofacial surgery during endoscopic and other instrumental examinations. Dosing and Administration of drugs: lidocaine before administration to conduct test for sensitivity to achieve the antiarrhythmic action, starting with the introduction of bolus / v at a dose of 1-2 mg / kg Acute Myeloid Leukemia weight hairy 3-4 minutes, the average single dose - 80 mg maximum single dose - 100 mg, then move on drip infusion at a speed of here mg / kg hairy min (maximum 2 mg / min) in 5% of the district not glucose or physiological district is here drip infusions may be used within 24 - 36 hours, if whole body radiation background drop infusion can be repeated at / in here at a dose of 40 mg over 10 minutes after the Otitis Media with Effusion bolus. when intercostal blockade effect lasts 7 - 14 h of here blockade - 3-4 h blockade of abdominal muscles - 45-60 min.; bupivacaine easily soluble Right Middle Lobe-lung fats.